The aim of the present randomized-controlled study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for brain cancer survivors.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Self-reported cognitive functioning
Timeframe: Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Carer-reported cognitive functioning
Timeframe: Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Self-reported neurobehavioral functioning
Timeframe: Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)
Carer-reported neurobehavioral functioning
Timeframe: Baseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)